CIK 0001581280 · Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462058888
- Phone
- 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $99,863,292
- in 32 filings, $84.3M under 10b5-1 plans
Net −$99,863,292. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −32,300 | 0 | ||
| 2026-02-17 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −18,205 | 0 | ||
| 2026-02-13 | CHESS ROBERT Director | Sale | −2,184 | $48.26 | $105K | 21,084 |
| 2026-02-13 | Finn Patrick John President and COO | Option exercise 10b5-1 | +500 | $23.33 | $12K | 307,288 |
| 2026-02-13 | Finn Patrick John President and COO | Option exercise 10b5-1 | +712 | $26.66 | $19K | 308,000 |
| 2026-02-13 | Finn Patrick John President and COO | Sale 10b5-1 | −1,750 | $50.04 | $88K | 306,250 |
| 2026-02-13 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −712 | 32,300 | ||
| 2026-02-13 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −500 | 18,052 | ||
| 2026-02-12 | Finn Patrick John President and COO | Option exercise 10b5-1 | +1,000 | $23.33 | $23K | 308,788 |
| 2026-02-12 | Finn Patrick John President and COO | Option exercise 10b5-1 | +1,500 | $26.66 | $40K | 310,288 |
| 2026-02-12 | Finn Patrick John President and COO | Sale 10b5-1 | −3,500 | $50.23 | $176K | 306,788 |
| 2026-02-12 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 33,012 | ||
| 2026-02-12 | Finn Patrick John President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −1,000 | 18,705 | ||
| 2026-02-12 | Laponis Adam Chief Financial Officer | Sale 10b5-1 | −7,000 | $50.00 | $350K | 130,031 |
Page 10 of 10 · 194 trades